ANASTROZOLE ERIS anastrozole 1 mg film-coated tablet blister pack

Active ingredient:

anastrozole, Quantity: 1 mg

Available from:

Strides Pharma Science Pty Ltd

INN (International Name):

Anastrozole

Pharmaceutical form:

Tablet, film coated

Composition:

Excipient Ingredients: sodium starch glycollate; lactose monohydrate; hypromellose; magnesium stearate; povidone; titanium dioxide; macrogol 400

Administration route:

Oral

Units in package:

30 tablets

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

First line treatment of advanced breast cancer in postmenopausal women with oestrogen/progesterone receptor positive disease. Treatment of advanced breast cancer in postmenopausal women with disease progression following tamoxifen therapy. Patients with oestrogen receptor negative disease and patients who have not responded to previous tamoxifen therapy rarely respond to ANASTROZOLE ERIS.

Product summary:

Visual Identification: White to off-white, round, biconvex film coated tablet engraved with the letters "A 1" on one side and plain on the other; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 30 degrees Celsius

Authorization status:

Licence status A

Authorization date:

2012-09-24